67 related articles for article (PubMed ID: 38456650)
21. Effectiveness of Molecular Testing Techniques for Diagnosis of Indeterminate Thyroid Nodules: A Randomized Clinical Trial.
Livhits MJ; Zhu CY; Kuo EJ; Nguyen DT; Kim J; Tseng CH; Leung AM; Rao J; Levin M; Douek ML; Beckett KR; Cheung DS; Gofnung YA; Smooke-Praw S; Yeh MW
JAMA Oncol; 2021 Jan; 7(1):70-77. PubMed ID: 33300952
[TBL] [Abstract][Full Text] [Related]
22. The relation between BRAFV600E mutation and clinicopathological characteristics of papillary thyroid cancer.
Celik M; Bulbul BY; Ayturk S; Durmus Y; Gurkan H; Can N; Tastekin E; Ustun F; Sezer A; Guldiken S
Med Glas (Zenica); 2020 Feb; 17(1):30-34. PubMed ID: 31994851
[TBL] [Abstract][Full Text] [Related]
23. RET fusions in solid tumors.
Li AY; McCusker MG; Russo A; Scilla KA; Gittens A; Arensmeyer K; Mehra R; Adamo V; Rolfo C
Cancer Treat Rev; 2019 Dec; 81():101911. PubMed ID: 31715421
[TBL] [Abstract][Full Text] [Related]
24. Assessment of The Bethesda System for Reporting Thyroid Cytopathology.
Sauter JL; Lehrke H; Zhang X; Al Badri OT; Rodriguez-Gutierrez R; Delivanis DA; Singh Ospina N; Donegan D; Hamidi O; Iñiguez-Ariza N; Sharma A; Kittah NEN; Tamhane SU; Hurtado Andrade MD; Kotwal A; Jenkins SM; Spears G; Rivera M; Dean DS; Henry MR
Am J Clin Pathol; 2019 Sep; 152(4):502-511. PubMed ID: 31305880
[TBL] [Abstract][Full Text] [Related]
25. Cancer statistics, 2019.
Siegel RL; Miller KD; Jemal A
CA Cancer J Clin; 2019 Jan; 69(1):7-34. PubMed ID: 30620402
[TBL] [Abstract][Full Text] [Related]
26. Performance of a Genomic Sequencing Classifier for the Preoperative Diagnosis of Cytologically Indeterminate Thyroid Nodules.
Patel KN; Angell TE; Babiarz J; Barth NM; Blevins T; Duh QY; Ghossein RA; Harrell RM; Huang J; Kennedy GC; Kim SY; Kloos RT; LiVolsi VA; Randolph GW; Sadow PM; Shanik MH; Sosa JA; Traweek ST; Walsh PS; Whitney D; Yeh MW; Ladenson PW
JAMA Surg; 2018 Sep; 153(9):817-824. PubMed ID: 29799911
[TBL] [Abstract][Full Text] [Related]
27. Role and relevance of BRAF mutations in risk stratifying patients of papillary thyroid cancers along with a review of literature.
Krishnamurthy A; Ramshankar V; Murherkar K; Vidyarani S; Raghunandhan GC; Das A; Desai PB; Albert K
Indian J Cancer; 2017; 54(1):372-378. PubMed ID: 29199726
[TBL] [Abstract][Full Text] [Related]
28. Genetic landscape of papillary thyroid carcinoma in the Chinese population.
Liang J; Cai W; Feng D; Teng H; Mao F; Jiang Y; Hu S; Li X; Zhang Y; Liu B; Sun ZS
J Pathol; 2018 Feb; 244(2):215-226. PubMed ID: 29144541
[TBL] [Abstract][Full Text] [Related]
29. The 2017 Bethesda System for Reporting Thyroid Cytopathology.
Cibas ES; Ali SZ
Thyroid; 2017 Nov; 27(11):1341-1346. PubMed ID: 29091573
[TBL] [Abstract][Full Text] [Related]
30. Molecular Profiling of Papillary Thyroid Carcinoma in Korea with a High Prevalence of BRAF
Lee SE; Hwang TS; Choi YL; Kim WY; Han HS; Lim SD; Kim WS; Yoo YB; Kim SK
Thyroid; 2017 Jun; 27(6):802-810. PubMed ID: 28293988
[TBL] [Abstract][Full Text] [Related]
31. In Japanese patients with papillary thyroid carcinoma, TERT promoter mutation is associated with poor prognosis, in contrast to BRAF
Nasirden A; Saito T; Fukumura Y; Hara K; Akaike K; Kurisaki-Arakawa A; Asahina M; Yamashita A; Tomomasa R; Hayashi T; Arakawa A; Yao T
Virchows Arch; 2016 Dec; 469(6):687-696. PubMed ID: 27718012
[TBL] [Abstract][Full Text] [Related]
32. Tissue-specific mutation accumulation in human adult stem cells during life.
Blokzijl F; de Ligt J; Jager M; Sasselli V; Roerink S; Sasaki N; Huch M; Boymans S; Kuijk E; Prins P; Nijman IJ; Martincorena I; Mokry M; Wiegerinck CL; Middendorp S; Sato T; Schwank G; Nieuwenhuis EE; Verstegen MM; van der Laan LJ; de Jonge J; IJzermans JN; Vries RG; van de Wetering M; Stratton MR; Clevers H; Cuppen E; van Boxtel R
Nature; 2016 Oct; 538(7624):260-264. PubMed ID: 27698416
[TBL] [Abstract][Full Text] [Related]
33. Thyroid cancer.
Cabanillas ME; McFadden DG; Durante C
Lancet; 2016 Dec; 388(10061):2783-2795. PubMed ID: 27240885
[TBL] [Abstract][Full Text] [Related]
34. A 2015 Survey of Clinical Practice Patterns in the Management of Thyroid Nodules.
Burch HB; Burman KD; Cooper DS; Hennessey JV; Vietor NO
J Clin Endocrinol Metab; 2016 Jul; 101(7):2853-62. PubMed ID: 27014951
[TBL] [Abstract][Full Text] [Related]
35. Risk Stratification in Differentiated Thyroid Cancer: An Ongoing Process.
Omry-Orbach G
Rambam Maimonides Med J; 2016 Jan; 7(1):. PubMed ID: 26886959
[TBL] [Abstract][Full Text] [Related]
36. Ongoing risk stratification for differentiated thyroid cancer (DTC) - stimulated serum thyroglobulin (Tg) before radioiodine (RAI) ablation, the most potent risk factor of cancer recurrence in M0 patients.
Krajewska J; Jarząb M; Czarniecka A; Roskosz J; Kukulska A; Handkiewicz-Junak D; Puch Z; Wygoda Z; Paliczka-Cieślik E; Kropińska A; Gubała E; Jurecka-Lubieniecka B; Jarząb B
Endokrynol Pol; 2016; 67(1):2-11. PubMed ID: 26884109
[TBL] [Abstract][Full Text] [Related]
37. Association between BRAF and RAS mutations, and RET rearrangements and the clinical features of papillary thyroid cancer.
Ming J; Liu Z; Zeng W; Maimaiti Y; Guo Y; Nie X; Chen C; Zhao X; Shi L; Liu C; Huang T
Int J Clin Exp Pathol; 2015; 8(11):15155-62. PubMed ID: 26823860
[TBL] [Abstract][Full Text] [Related]
38. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer.
Haugen BR; Alexander EK; Bible KC; Doherty GM; Mandel SJ; Nikiforov YE; Pacini F; Randolph GW; Sawka AM; Schlumberger M; Schuff KG; Sherman SI; Sosa JA; Steward DL; Tuttle RM; Wartofsky L
Thyroid; 2016 Jan; 26(1):1-133. PubMed ID: 26462967
[TBL] [Abstract][Full Text] [Related]
39. BRAFV600E mutation in papillary thyroid microcarcinoma: a meta-analysis.
Li F; Chen G; Sheng C; Gusdon AM; Huang Y; Lv Z; Xu H; Xing M; Qu S
Endocr Relat Cancer; 2015 Apr; 22(2):159-68. PubMed ID: 25593071
[TBL] [Abstract][Full Text] [Related]
40. Integrated genomic characterization of papillary thyroid carcinoma.
Cancer Genome Atlas Research Network
Cell; 2014 Oct; 159(3):676-90. PubMed ID: 25417114
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
